Titan Pharmaceuticals
TTNP
#10393
Rank
HK$47.92 M
Marketcap
HK$36.03
Share price
-3.76%
Change (1 day)
21.61%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.31. In 2023 the company made an earnings per share (EPS) of -HK$57.91 an increase over its 2022 EPS that were of -HK$118.71.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.91-51.22%
2022-HK$118.71-15.61%
2021-HK$140.67-81.37%
2020-HK$754.91-77.52%
2019-HK$3,359-56.32%
2018-HK$7,690-59.51%
2017-HK$18,994-371.81%
2016HK$6,988-144.35%
2015-HK$15,755300%
2014-HK$3,939-121.54%
2013HK$18,287-151.38%
2012-HK$35,589-11.54%
2011-HK$40,231188.89%
2010-HK$13,926-10%
2009-HK$15,473
2007-HK$63,441-2.38%
2006-HK$64,988-39.13%
2005-HK$106,767-16.87%
2004-HK$128,430-22.43%
2003-HK$165,5664.9%
2002-HK$157,82961.9%
2001-HK$97,483-13.7%
2000-HK$112,95665.01%
1999-HK$68,455-35.87%
1998-HK$106,749-1824.71%
1997HK$6,189-102.4%
1996-HK$258,406

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.04-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.52-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.10-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.95-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.41-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA